SpiderRock Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
SpiderRock Advisors's PFE Position: Q3 2024 in Review
SpiderRock Advisors reduced its Pfizer (PFE) stake by 2.6% in Q3 2024, selling an estimated $156K and leaving 198,616 shares worth $5.75M. The position accounts for 0.09% of the portfolio, ranked #160.
SpiderRock Advisors first reported a position in PFE in Q1 2024 and has held it in 3 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- SpiderRock Advisors held 198,616 shares of Pfizer worth $5.75M as of Q3 2024.
- SpiderRock Advisors sold 5,353 Pfizer shares in Q3 2024, an estimated $156K.
- Pfizer made up 0.09% of SpiderRock Advisors's portfolio in Q3 2024, its #160 holding.
- SpiderRock Advisors first reported a position in Pfizer in Q1 2024 and has held it in 3 quarters since.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.